Dual diagnosis — also called co-occurring disorders — refers to the simultaneous presence of a mental health condition and a substance use disorder in the same person. This is not a rare combination: according to the National Survey on Drug Use and Health, approximately 9.5 million adults in the United States have both a mental illness and a substance use disorder. Yet many people receive treatment for only one condition, which significantly reduces the chances of lasting recovery.
Common dual diagnosis combinations include depression with alcohol use disorder, anxiety with benzodiazepine dependence, bipolar disorder with stimulant or alcohol misuse, PTSD with opioid use, and ADHD with cannabis or stimulant misuse. The relationship between these conditions is bidirectional — each one worsens the other.
Mental health conditions and substance use disorders share overlapping risk factors including genetics, brain chemistry, trauma history, and chronic stress. Many adults with untreated mental illness turn to alcohol or drugs as a way to self-medicate — using alcohol to ease social anxiety, stimulants to manage undiagnosed ADHD, or opioids to numb emotional pain from trauma.
Conversely, chronic substance use can cause or worsen mental health symptoms. Alcohol is a central nervous system depressant that can trigger or deepen depression. Stimulant withdrawal often produces severe anxiety and paranoia. Long-term cannabis use is associated with increased risk of psychosis in vulnerable individuals. And the cycle of intoxication and withdrawal itself creates neurochemical instability that mimics and exacerbates psychiatric conditions.
Treating only the substance use disorder without addressing the underlying mental health condition leaves the root cause of self-medication untreated — making relapse nearly inevitable. Similarly, treating only the mental health condition while substance use continues undermines medication effectiveness (alcohol reduces antidepressant efficacy, for example) and prevents meaningful therapeutic progress.
Integrated treatment addresses both conditions simultaneously with a coordinated approach. This typically combines psychiatric medication management (choosing medications with low abuse potential and no dangerous interactions with substances), evidence-based psychotherapy like CBT and motivational interviewing, and support for recovery and relapse prevention.
Medication selection in dual diagnosis requires special expertise. Psychiatrists must choose medications that effectively treat the psychiatric condition without reinforcing addictive patterns. For depression with alcohol use disorder, Wellbutrin or SSRIs like Zoloft are preferred over benzodiazepines. For anxiety with substance use history, non-addictive options like buspirone, hydroxyzine, or gabapentin are used instead of controlled substances.
For bipolar disorder with substance use, mood stabilizers like lithium and lamotrigine are cornerstone treatments — stabilizing mood reduces the impulsivity and desperation that drive substance use. For ADHD with substance use history, non-stimulant medications or the prodrug Vyvanse (which has lower abuse potential than other stimulants) may be considered once sobriety is established.
At Elevate Psychiatry, our board-certified psychiatrists have expertise in treating co-occurring mental health and substance use conditions in adults. We provide thorough diagnostic evaluations, careful medication selection for dual diagnosis, and coordination with addiction treatment providers when needed. We serve patients in Miami and throughout Florida via telehealth.
Schedule an appointment for a comprehensive evaluation.
One of the most common dual diagnosis combinations is alcohol use and depression, which require integrated treatment addressing both conditions simultaneously.
